About Axiogenesis
Axiogenesis is a company based in Koln (Germany) founded in 2000. Axiogenesis operates in a competitive market with competitors including MAYD, medpex, Medizinfuchs, FIRST A and Sanicare, among others.
- Headquarter Koln, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$403.09 K (USD)19.31as on Mar 31, 2022
-
Net Profit
$26.11 K (USD)-14.87as on Mar 31, 2022
-
EBITDA
$31.2 K (USD)28.43as on Mar 31, 2022
-
Latest Funding Round
$615.66 K (USD), Grant
Nov 01, 2016
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Axiogenesis
Investors in Axiogenesis
Axiogenesis has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Huizhong Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Huizhong Diagnostics is engaged in developing medical diagnostic solutions.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Axiogenesis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Axiogenesis
Investment portfolio details for Axiogenesis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Axiogenesis
Detailed financials for Axiogenesis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Axiogenesis Comparisons
Peer comparison for Axiogenesis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Axiogenesis
Axiogenesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MAYD, medpex, Medizinfuchs, FIRST A and Sanicare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-prescription medicines are ordered and delivered online.
|
|
| Locked | Locked | Locked |
Medicines for health conditions are sold online by medpex.
|
|
| Locked | Locked | Locked |
Operates a marketplace for pharmacy products to facilitate online purchasing.
|
|
| Locked | Locked | Locked |
A mobile app for online medicine ordering is provided.
|
|
| Locked | Locked | Locked |
Online pharmacy products are offered across various health categories.
|
Detailed competitors of Axiogenesis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Axiogenesis
Complete news archive for Axiogenesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axiogenesis
Axiogenesis was founded in 2000 and raised its 1st funding round 15 years after it was founded.
Axiogenesis is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.
Annual revenue of Axiogenesis is $403.09K as on Mar 31, 2022.
Axiogenesis was established in 2000 in Cologne, Germany, as an online pharmacy. Generic medicines are distributed through the platform, which operates in the healthcare sector. Specific drugs can be searched by users according to their requirements. The service focuses on pharmaceutical accessibility, with operations centered in Europe. The domain axiogenesis.com supports these activities.
Axiogenesis has 2 investors. Key investors include European Union, and Huizhong Diagnostics.